Contract manufacturing

Looking for a partner who can guarantee high-quality pharmaceutical manufacturing compliant with international standards? We offer flexible collaboration models – from product and formulation development, through technology transfer, to full-scale manufacturing of finished medicinal products. Our state-of-the-art facilities are designed to produce a wide portfolio of forms and doses – including highly potent medicines (up to OEB 5) – ensuring full process integrity and operator safety.

We manufacture over 25 million packages annually, handling both small batches and large-scale volumes. The integration of R&D, quality control, and production enables us to efficiently scale up projects to industrial production. We focus on a partnership-based approach that ensures predictability, efficiency, and full compliance with EU cGMP, FDA, and EAEU requirements.

Learn more about our contract manufacturing capabilities.

Possible cooperation models

CDMO
CMO
Licence-In
Licence-Out

Produced pharmaceutical forms

Tablets and capsules
Powders for suspension
Lyophilisates for injectable solutions
Injectable solutions and suspensions
Gels and pharmaceutical aerosols
Tablets and capsules
Powders for suspension
Lyophilisates for injectable solutions
Injectable solutions and suspensions
Gels and pharmaceutical aerosols
Tablets and capsules
Powders for suspension
Lyophilisates for injectable solutions
Injectable solutions and suspensions
Gels and pharmaceutical aerosols
Tablets and capsules
Powders for suspension
Lyophilisates for injectable solutions
Injectable solutions and suspensions
Gels and pharmaceutical aerosols

Pharmaceutical forms

Powders for suspension or solution for injection and infusion
Lyophilised powder for suspension or solution for injection and infusion

Primary packaging

Glass vials (dry powder filling) 20R, 50R, 100R and 200R, flip-off cap
Glass vials (dry powder filling/lyophilisation) 2R, 6R, 10R, 20R, 30R, 50R, flip-off cap

Secondary packaging

Folding boxes for individual vials

New production facilities

Available from Q3 2028 (lyophilisation)

Estimated annual capacities

From 2 million (lyophilisation) to 15 million (filling) vials

Pharmaceutical forms

Solutions in glass ampoules
Solutions or suspensions in glass cartridges
Solutions in glass vials

Primary packaging

Ampoules 2 ml and 5 ml
Cartridges 3 ml
Vials 2R, 6R, 10R, 20R, 30R, 50R

Secondary packaging

Folding boxes for individual vials, or in multiples of 5 or 10 for ampoules and cartridges

Estimated annual capacities

10 million ampules
6 million cartridges
10 million vials

Pharmaceutical forms

Solutions in glass vials
Solutions in prefilled syringes (PFSs)
Lyophilised powder for injection in vials

Primary packaging

Prefilled syringes 0.5 ml, 1 ml, 5 ml
Vials 2R, 8R, 10R, 30R, 50R

Secondary packaging

Folding boxes for individual vials or prefilled syringes

New production facilities

Available from Q4 2027

Estimated annual capacities

From 0.6 million (lyophilisation) to 3 million (filling) vials or prefilled syringes

Pharmaceutical forms

Tablets and film-coated tablets (sugar, organic solvent); size 5–19 mm
Hard gelatine capsules; size 4–00
Dry powders or granulates for oral suspensions; dose 3–30 g

Primary packaging

Blisters: aluminium-aluminium (Alu-Alu), aluminium-polyvinyl chloride (Alu-PVC), polyvinylidene chloride (PVDC)
Containers and jars for tablets and capsules
Bottles (glass, plastic) in different sizes 30–200 ml for powders and granulates

Secondary packaging

Folding boxes in different sizes and configurations

Estimated annual capacities

100 million tablets or capsules
0.5 million bottles of dry powders

Why partner with us?

200 YEARS OF EXPERIENCE IN THE PHARMACEUTICAL INDUSTRY
Over two centuries of experience have enabled us to develop a comprehensive pharmaceutical offering that continues to evolve in response to the changing needs of patients and business partners.
CAPACITY TO MANUFACTURE HIGHLY POTENT MEDICINES
We manage projects involving high-potency compounds up to OEB 5 on state-of-the-art production lines, ensuring full process safety and compliance with cGMP (EU), FDA and EAEU requirements.
FULL PROCESS INTEGRATION UNDER ONE ROOF
We combine research, development, Quality Control (QC) and industrial-scale production to ensure fast, reliable and scalable project delivery while maintaining full process oversight.
COMPREHENSIVE PORTFOLIO OF DOSAGE FORMS
We specialise in the production of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Our facilities produce over 50 products in more than 130 forms and doses – from tablets and capsules, through sterile injections and lyophilisates, to aerosols and gels.
FLEXIBLE COOPERATION MODELS
We tailor our partnership models to individual project needs – CDMO, CMO, Licence-In & Licence-Out – ensuring flexibility at every stage of collaboration.
VARIOUS THERAPEUTIC CLASSES
We specialise in antibiotics, human insulins, dermatological and central nervous system (CNS) medicines, offering expert knowledge and experience across each therapeutic area.